drugset / Trial / NCT04388527
COVID-19 Convalescent Plasma for Mechanically Ventilated Population
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to see if this plasma can be safely used in humans with COVID-19 and to see if it can improve patients' health when they are sick with COVID-19.
Timeline
- Start
- 2020-04-30
- Primary completion
- 2021-01-25
- Completion
- 2021-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Convalescent Plasma | Protein / enzyme biologic | 2 unknown | — |